142843-07-0

Basic information

• Product Name: ethyl 2-<<(2R,3S)-3-<(tert-butoxycarbonyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>thio>acetate
• Synonyms: ethyl 2-<<(2R,3S)-3-<(tert-butoxycarbonyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>thio>acetate
• CAS NO: 142843-07-0
• Molecular Weight: 389.557
• Mol File: 142843-07-0.mol

Chemical Properties

• CAS DataBase Reference: ethyl 2-<<(2R,3S)-3-<(tert-butoxycarbonyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>thio>acetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-<<(2R,3S)-3-<(tert-butoxycarbonyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>thio>acetate(142843-07-0)
• EPA Substance Registry System: ethyl 2-<<(2R,3S)-3-<(tert-butoxycarbonyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>thio>acetate(142843-07-0)

Safety Data

• Hazardous Substances Data: 142843-07-0(Hazardous Substances Data)

Upstream product

• 107202-61-9 (2R,3S)-3-(t-butoxycarbonylamino)-4-cyclohexyl-1,2-epoxybutane 
• 623-51-8 ethyl 2-sulfanylacetate 

Downstream Products

• 142843-10-5 4-[2-[[(2R,3S)-3-(t-Butoxycarbonylamino)-4-cyclohexyl-2-hydroxy-1-butyl]thio]acetyl]-1-methylpiperazine 
• 142843-11-6 3-<2-<<(2R,3S)-3-<(tert-butoxycarbonyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>thio>acetamido>quinuclidine 
• 142843-09-2 ethyl 2-<<(2R,3S)-3-<(tert-butoxycarbonyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>sulfonyl>acetate 
• 142843-22-9 4-((S)-2-((S)-2-tert-Butoxycarbonylamino-3-phenyl-propionylamino)-2-{(1S,2R)-1-cyclohexylmethyl-2-hydroxy-3-[(1-oxy-1-aza-bicyclo[2.2.2]oct-3-ylcarbamoyl)-methanesulfonyl]-propylcarbamoyl}-ethyl)-imidazole-1-carboxylic acid tert-butyl ester 
• 142843-21-8 4-[(S)-2-{(1S,2R)-3-[(1-Aza-bicyclo[2.2.2]oct-3-ylcarbamoyl)-methylsulfanyl]-1-cyclohexylmethyl-2-hydroxy-propylcarbamoyl}-2-((S)-2-tert-butoxycarbonylamino-3-phenyl-propionylamino)-ethyl]-imidazole-1-carboxylic acid tert-butyl ester 
• 142843-35-4 {(S)-1-[(S)-1-{(1S,2R)-3-[(1-Benzyl-piperidin-4-ylcarbamoyl)-methanesulfonyl]-1-cyclohexylmethyl-2-hydroxy-propylcarbamoyl}-2-(1H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester 
• 143396-51-4 {(S)-1-[(S)-1-{(1S,2R)-1-Cyclohexylmethyl-2-hydroxy-3-[(1-oxy-1-aza-bicyclo[2.2.2]oct-3-ylcarbamoyl)-methanesulfonyl]-propylcarbamoyl}-2-(1H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester 
• 142843-17-2 4-[(S)-2-((S)-2-tert-Butoxycarbonylamino-3-phenyl-propionylamino)-2-((1S,2R)-1-cyclohexylmethyl-3-ethoxycarbonylmethanesulfonyl-2-hydroxy-propylcarbamoyl)-ethyl]-imidazole-1-carboxylic acid tert-butyl ester 
• 142866-95-3 4-((S)-2-((S)-2-tert-Butoxycarbonylamino-3-phenyl-propionylamino)-2-{(1S,2R)-1-cyclohexylmethyl-2-hydroxy-3-[2-(4-methyl-piperazin-1-yl)-2-oxo-ethylsulfanyl]-propylcarbamoyl}-ethyl)-imidazole-1-carboxylic acid tert-butyl ester 
• 142843-14-9 4-<2-<2-<<(2R,3S)-3-<α-<(S)-2-<(tert-butylsulfonyl)methyl>-3-phenylpropionyl>-L-histidyl>amino>-4-cyclohexyl-2-hydroxy-1-butyl>sulfonyl>acetamido>ethyl>morpholine 
• 142843-33-2 {(S)-1-[(S)-1-{(1S,2R)-1-Cyclohexylmethyl-2-hydroxy-3-[(2-morpholin-4-yl-ethylcarbamoyl)-methanesulfonyl]-propylcarbamoyl}-2-(1H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester 
• 142843-19-4 ethyl 2-<<(2R,3S)-3-<(Boc-L-phenylalanyl-N^im-Boc-L-histidyl)amino>-4-cyclohexyl-2-hydroxy-1-butyl>sulfinyl>acetate 
• 142843-32-1 {(S)-1-[(S)-1-{(1S,2R)-1-Cyclohexylmethyl-2-hydroxy-3-[(2-morpholin-4-yl-ethylcarbamoyl)-methanesulfinyl]-propylcarbamoyl}-2-(1H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester 
• 142843-34-3 {(S)-1-[(S)-1-{(1S,2R)-1-Cyclohexylmethyl-2-hydroxy-3-[2-(4-methyl-piperazin-1-yl)-2-oxo-ethanesulfonyl]-propylcarbamoyl}-2-(1H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester 

Relevant articles and documents

Inhibitors of Human Renin with C-Termini Derived from Amides and Esters of α-Mercaptoalkanoic Acids

New transition-state analogues bearing C-termini derived from α-mercaptoalkanoic acids, esters, and amides were prepared and evaluated as inhibitors of human renin.Addition of α-mercaptoalkanoate esters to a chiral Boc-amino epoxide intermediate led ultim

RENIN INHIBITORS CONTAINING THE 2-[[(2R,3S)-3-AMINO-4-CYCLOHEXYL-2-HYDROXY-1-BUTYL]THIO]ALKANOYL MOIETY AND THE CORRESPONDING SULFOXIDE AND SULFONE DERIVATIVES

Compounds of the formula: STR1 which are potent inhibitors of human renin and are useful for treating various forms of renin-associated hypertension, hyperaldosteronism and congestive heart failure; compositions containing these renin-inhibitory compounds